Astepro Launch And Strong Cold Season Boost Bayer In Q3
The US OTC launch of reclassified nasal spray Astepro Allergy, in combination with “continuously elevated cold incidence rates,” helped to drive up Bayer's Consumer Health sales at a double-digit rate in Q3.
You may also be interested in...
Bayer Relates Feeling ‘Sexy’ To Quick Relief For Allergies In Astepro Allergy Ad Campaign
Campaign featuring actress Meghann Fahy says "allergy sufferers can relieve their allergy symptoms and be more spontaneous in their romantic pursuits.” Ads launch two months after FDA granted tentative approval for two ANDAs for generic equivalents, indicating approval could come pending resolution of patent litigation.
Top Five Takeaways From Bayer Consumer Health's 2022 Results
Beating global market growth, continuing macroeconomic headwinds and spin-off perspectives were among the key talking points as Bayer Consumer Health reported its 2022 sales and earnings.
Bayer Aspirin Tackles Cardiovascular Risks In ‘Official Sponsor Of Fans’ Hearts’ Campaign
It’s airing campaign ads during regional NBC Sports broadcasts and nationally on FOX, ESPN, ESPN2 and NBA TV starting 6 February. While Super Bowl annually is among most watched TV programs worldwide, Bayer notes in 2021 around 57.5m US viewers watched digital live sports at least once a month.